Advanced Heart Failure and Transplant Cardiology · Iowa City, IA
NPI
1437121407
Since 2006
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
200 Hawkins Dr
Iowa City, IA, 52242
Phone (319) 353-7428
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
340 services
Medicare patients, 2024
174
Average age 71
Drug cost, 2024
$15.8M
2,714 prescriptions
Company payments, 2025
$75.89
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Linda M Cadaret was code 99233 (hospital e&m - subsequent), 80 times for 31 patients. In total Linda M Cadaret billed 340 services in 14 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 80 | 31 | $84.58 | $6,766 |
| 99214 Office E&M - Established | Facility | 71 | 58 | $65.67 | $4,662 |
| 99215 Office E&M - Established | Facility | 49 | 42 | $96.42 | $4,725 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 22 | $54.25 | $1,953 |
| 99205 Office E&M - New | Facility | 21 | 21 | $126.31 | $2,653 |
| 99222 Hospital E&M - Initial | Facility | 17 | 15 | $89.54 | $1,522 |
| 99215 Office E&M - Established | Office | 16 | 13 | $124.44 | $1,991 |
| 99204 Office E&M - New | Facility | 14 | 14 | $90.33 | $1,265 |
| 99214 Office E&M - Established | Office | 11 | 11 | $90.15 | $992 |
By year: 2022 $38K for 465 services; 2023 $32K for 371 services; 2024 $29K for 340 services.
Medicare prescription drug claims, 2024
In 2024, the drug Linda M Cadaret prescribed most often to Medicare patients was Opsumit (Macitentan), with 291 prescriptions and refills. In total Linda M Cadaret wrote 2,714 Medicare prescriptions that cost $15.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 291 | 291 | 40 | $3.7M |
| Sildenafil Citrate Generic | 235 | 293 | 36 | $56K |
| Tadalafil Generic | 146 | 179 | 29 | $122K |
| Potassium Chloride Generic | 140 | 297 | 36 | $3,356 |
| Uptravi Selexipag | 137 | 137 | 14 | $3.0M |
| Tyvaso Dpi Treprostinil | 133 | 133 | 20 | $3.1M |
| Entresto Sacubitril/Valsartan | 114 | 212 | 28 | $133K |
| Ambrisentan Generic | 112 | 112 | 16 | $271K |
| Furosemide Generic | 99 | 251 | 39 | $923 |
| Adempas Riociguat | 95 | 95 | Under 11 | $1.3M |
| Winrevair Sotatercept-Csrk | 94 | 94 | 23 | $1.6M |
| Metoprolol Succinate Generic | 86 | 188 | 23 | $998 |
| Spironolactone Generic | 80 | 221 | 29 | $465 |
| Jardiance Empagliflozin | 74 | 127 | 19 | $73K |
| Torsemide Generic | 62 | 116 | 17 | $1,797 |
Brand drugs: - claims; generic drugs: 1,518 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Linda M Cadaret $75.89 ($75.89 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbott Laboratories with $70.61.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.